Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-07-10 16:41 |
Purple Biotech to Host Virtual KOL Event to Discuss Positive Interim Results fr…
|
English | 2.8 MB | ||
| 2024-07-10 16:41 |
Purple Biotech to Host Virtual KOL Event to Discuss Positive Interim Results fr…
|
English | 36.8 KB | ||
| 2024-07-03 03:27 |
PROSPECTUS SUPPLEMENT (To Prospectus Supplements Dated October 19, 2023 and Jun…
|
English | 99.3 KB | ||
| 2024-07-03 03:27 |
PROSPECTUS SUPPLEMENT (To Prospectus Supplements Dated October 19, 2023 and Jun…
|
English | 35.9 KB | ||
| 2024-07-03 03:21 |
6K: Inducement Offer to Exercise Existing Warrants to Purchase Ordinary Shares …
|
English | 536.5 KB | ||
| 2024-07-03 03:21 |
6K: Inducement Offer to Exercise Existing Warrants to Purchase Ordinary Shares …
|
English | 36.5 KB | ||
| 2024-07-03 03:18 |
6K-Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gros…
|
English | 190.9 KB | ||
| 2024-07-03 03:18 |
6K-Purple Biotech Announces Closing of Exercise of Warrants for $2 Million Gros…
|
English | 36.6 KB | ||
| 2024-07-01 18:13 |
Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds
|
English | 165.5 KB | ||
| 2024-07-01 18:13 |
Purple Biotech Announces Exercise of Warrants for $2 Million Gross Proceeds
|
English | 36.6 KB | ||
| 2024-06-27 16:58 |
Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Canc…
|
English | 230.4 KB | ||
| 2024-06-27 16:58 |
Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Canc…
|
English | 36.8 KB | ||
| 2024-06-27 01:49 |
Immediate Report of Meeting To Be Held on August 8, 2024, PROXY STATEMENT
|
English | 464.2 KB | ||
| 2024-06-27 01:49 |
Immediate Report of Meeting To Be Held on August 8, 2024, PROXY STATEMENT
|
English | 1.0 MB | ||
| 2024-06-27 01:49 |
Immediate Report of Meeting To Be Held on August 8, 2024, PROXY STATEMENT
|
English | 80.6 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
